Skip to content

Shao-Lee Lin, Chief Executive Officer at Cue Biopharma, sold CUE on Aug 13, 2026

Data as of Oct 16

▼ SELL$66.8K2,375 shares at $28.11Shao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.
Watch CUE
Traded
Aug 13, 2026
Disclosed
Aug 14, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Shao-Lee Lin, Chief Executive Officer at Cue Biopharma, sold CUE on Aug 13, 2026TRADEDDISCLOSED
CUESimilar stocks (XLV — its sector index fund), rebased to CUE's price on the disclosure day
CUE since disclosure
−51.1%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Aug 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$308Kdisclosed Aug 14 · filed 1 day after the trade
  2. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$147Kdisclosed Aug 14 · filed 1 day after the trade
  3. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$924Kdisclosed Aug 14 · filed 2 days after the trade
  4. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$160Kdisclosed Aug 14 · filed 2 days after the trade

See every trade on CUE →